Literature DB >> 9640302

An epidemic of renal failure among Australian Aboriginals.

J L Spencer1, D T Silva, P Snelling, W E Hoy.   

Abstract

OBJECTIVE: To define recent trends (1993-1996) in incidence of endstage renal disease (ESRD) among Australian Aboriginal people in the Top End of the Northern Territory (NT).
DESIGN: Analysis of hospital and clinical records of the Darwin-based ESRD treatment program from 1993 to 1996 and comparison with data accumulated since 1978. PARTICIPANTS: All people entering the ESRD treatment program from 1978 to 1996. MAIN OUTCOME MEASURES: Number of patients treated for ESRD; their ethnicity, age and sex; comorbidities in Aboriginal patients; treatment methods and outcomes.
RESULTS: More Aboriginal people presented with ESRD between 1993 and 1996 (87) than in the previous 15 years of the program (68). The incidence of ESRD in Aboriginals reached 838 per million in 1996, and is doubling every 4 years. Aboriginal people presenting with ESRD are younger than non-Aboriginal people with ESRD, and, in contrast to non-Aboriginals, ESRD rates are higher in women than men. The numbers and proportions of Aboriginal ESRD patients who have hypertension, type 2 diabetes and cardiac disease are rising. Haemodialysis remains the most common form of treatment, and the number of dialysis treatments is doubling every 2.5 years. Only 9% of Aboriginal patients entering the program in 1993-1996 were treated with chronic ambulatory peritoneal dialysis and only 3% received transplants. Despite their younger age, survival of Aboriginal people on dialysis is low (median 3.3 years v. 6.5 years in non-Aboriginals), and graft survival after transplant is poor (37% at 5 years v. 88% in non-Aboriginals). Survival has not improved in the past 4 years, with fewer deaths from infection offset by more deaths from cardiovascular disease.
CONCLUSIONS: The predicted doubling of ESRD incidence among Aboriginal people by the year 2000 will add an enormous burden to limited resources. Risk factors for renal disease underlie all the excess morbidity and mortality in NT Aboriginal adults, and arise out of accelerated lifestyle changes and socioeconomic disadvantage. Better living conditions and education, robust and integrated primary healthcare programs, and systematic screening for early renal disease and treatment of those with established disease are all matters of urgency.

Entities:  

Mesh:

Year:  1998        PMID: 9640302     DOI: 10.5694/j.1326-5377.1998.tb139080.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  15 in total

1.  The analytical quality of point-of-care testing in the 'QAAMS' model for diabetes management in Australian aboriginal medical services.

Authors:  Mark D S Shephard; Janice P Gill
Journal:  Clin Biochem Rev       Date:  2006-11

Review 2.  Clinical features and epidemiology of melioidosis pneumonia: results from a 21-year study and review of the literature.

Authors:  Ella M Meumann; Allen C Cheng; Linda Ward; Bart J Currie
Journal:  Clin Infect Dis       Date:  2011-11-04       Impact factor: 9.079

Review 3.  The organization and funding of the treatment of end-stage renal disease in Australia.

Authors:  Anthony Harris
Journal:  Int J Health Care Finance Econ       Date:  2007-09

4.  Infant and fetal mortality among a high fertility and mortality population in the Bolivian Amazon.

Authors:  Michael Gurven
Journal:  Soc Sci Med       Date:  2012-10-10       Impact factor: 4.634

Review 5.  Sociodemographic determinants of chronic kidney disease in Indigenous children.

Authors:  Allison Dart
Journal:  Pediatr Nephrol       Date:  2021-05-25       Impact factor: 3.714

6.  The predictive value of albuminuria for renal and nonrenal natural deaths over 14 years follow-up in a remote aboriginal community.

Authors:  Zaimin Wang; Wendy E Hoy
Journal:  Clin Kidney J       Date:  2012-10-26

7.  Kidney disease in Aboriginal Australians: a perspective from the Northern Territory.

Authors:  Wendy E Hoy
Journal:  Clin Kidney J       Date:  2014-11-13

8.  Survival of patients from South Asian and Black populations starting renal replacement therapy in England and Wales.

Authors:  Paul Roderick; Catherine Byrne; Anna Casula; Retha Steenkamp; David Ansell; Richard Burden; Dorothea Nitsch; Terry Feest
Journal:  Nephrol Dial Transplant       Date:  2009-07-21       Impact factor: 5.992

9.  The correlates of urinary albumin to creatinine ratio (ACR) in a high risk Australian aboriginal community.

Authors:  Zaimin Wang; Wendy E Hoy; Zhiqiang Wang
Journal:  BMC Nephrol       Date:  2013-08-16       Impact factor: 2.388

10.  Chronic kidney disease in the Top End of the Northern Territory of Australia, 2002-2011: a retrospective cohort study using existing laboratory data.

Authors:  Paul D Lawton; Joan Cunningham; Narelle Hadlow; Yuejen Zhao; Matthew D Jose
Journal:  BMC Nephrol       Date:  2015-10-22       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.